Oreshkova N - Search Results

1

Creation of a nonspreading Rift Valley fever virus.

Kortekaas J, Oreshkova N, Cobos-Jiménez V, Vloet RP, Potgieter CA, Moormann RJ. Kortekaas J, et al. Among authors: oreshkova n. J Virol. 2011 Dec;85(23):12622-30. doi: 10.1128/JVI.00841-11. Epub 2011 Sep 28. J Virol. 2011. PMID: 21957302 Free PMC article.

2

Efficacy of three candidate Rift Valley fever vaccines in sheep.

Kortekaas J, Antonis AF, Kant J, Vloet RP, Vogel A, Oreshkova N, de Boer SM, Bosch BJ, Moormann RJ. Kortekaas J, et al. Among authors: oreshkova n. Vaccine. 2012 May 14;30(23):3423-9. doi: 10.1016/j.vaccine.2012.03.027. Epub 2012 Mar 24. Vaccine. 2012. PMID: 22449427

3

A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs.

Oreshkova N, van Keulen L, Kant J, Moormann RJ, Kortekaas J. Oreshkova N, et al. PLoS One. 2013 Oct 22;8(10):e77461. doi: 10.1371/journal.pone.0077461. eCollection 2013. PLoS One. 2013. PMID: 24167574 Free PMC article.

4

Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.

Wichgers Schreur PJ, Oreshkova N, Moormann RJ, Kortekaas J. Wichgers Schreur PJ, et al. Among authors: oreshkova n. J Virol. 2014 Sep;88(18):10883-93. doi: 10.1128/JVI.00961-14. Epub 2014 Jul 9. J Virol. 2014. PMID: 25008937 Free PMC article.

5

Comparative efficacy of two next-generation Rift Valley fever vaccines.

Kortekaas J, Oreshkova N, van Keulen L, Kant J, Bosch BJ, Bouloy M, Moulin V, Goovaerts D, Moormann RJ. Kortekaas J, et al. Among authors: oreshkova n. Vaccine. 2014 Sep 3;32(39):4901-8. doi: 10.1016/j.vaccine.2014.07.037. Epub 2014 Jul 19. Vaccine. 2014. PMID: 25050973

6

Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen.

Oreshkova N, Cornelissen LA, de Haan CA, Moormann RJ, Kortekaas J. Oreshkova N, et al. Vaccine. 2014 Sep 15;32(41):5323-9. doi: 10.1016/j.vaccine.2014.07.051. Epub 2014 Jul 25. Vaccine. 2014. PMID: 25066737

7

Paramyxovirus-based production of Rift Valley fever virus replicon particles.

Wichgers Schreur PJ, Oreshkova N, Harders F, Bossers A, Moormann RJM, Kortekaas J. Wichgers Schreur PJ, et al. Among authors: oreshkova n. J Gen Virol. 2014 Dec;95(Pt 12):2638-2648. doi: 10.1099/vir.0.067660-0. Epub 2014 Sep 10. J Gen Virol. 2014. PMID: 25209808

8

Preliminary Evaluation of a Bunyavirus Vector for Cancer Immunotherapy.

Oreshkova N, Spel L, Vloet RP, Wichgers Schreur PJ, Moormann RJ, Boes M, Kortekaas J. Oreshkova N, et al. J Virol. 2015 Sep;89(17):9124-7. doi: 10.1128/JVI.01105-15. Epub 2015 Jun 17. J Virol. 2015. PMID: 26085169 Free PMC article.

9

Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells.

Oreshkova N, Wichgers Schreur PJ, Spel L, Vloet RP, Moormann RJ, Boes M, Kortekaas J. Oreshkova N, et al. PLoS One. 2015 Nov 17;10(11):e0142670. doi: 10.1371/journal.pone.0142670. eCollection 2015. PLoS One. 2015. PMID: 26575844 Free PMC article.

10

Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission.

Wichgers Schreur PJ, van Keulen L, Kant J, Oreshkova N, Moormann RJ, Kortekaas J. Wichgers Schreur PJ, et al. Among authors: oreshkova n. Front Microbiol. 2016 Mar 7;7:287. doi: 10.3389/fmicb.2016.00287. eCollection 2016. Front Microbiol. 2016. PMID: 27014211 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page